Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000041439Phase 4Recruiting
Phase 4 trial of remimazolam (2 arms), sponsored by Yantai Affiliated Hospital of Binzhou Medical College. Primary endpoints: haemodynamics, Intraoperative limb movement requiring intervention and 2 more. Started Jan 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000041439.